Serum TSH values during clinical controls of patients treated for congenital hypothyroidism;Valores elevados de TSH en los controles de tratamiento del hipotiroidismo congenito

Anales Espanoles de Pediatria

Volumn 46, Issue 2, 1997, Pages 167-171

  Peran Mesa S ^a,c   Gariga Cascon M J ^a   Lopez Siguero J P ^a   Peran Quesada M ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c UNIVERSIDAD DE MÁLAGA   (Spain)

Author keywords

congenital hypothyroidism; control; increased TSH

Indexed keywords

LEVOTHYROXINE SODIUM; THYROTROPIN;

ADULT; ARTICLE; CONGENITAL HYPOTHYROIDISM; DOSE RESPONSE; DRUG FORMULATION; DRUG MONITORING; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; THYROTROPIN BLOOD LEVEL;

ADULT; CONGENITAL HYPOTHYROIDISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; RANDOM ALLOCATION; RETROSPECTIVE STUDIES; THYROID HORMONES; THYROTROPIN;

EID: 0030975290     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Oppenheimer JH, Braverman LE, Toft A, Jackson IM, Ladenson PW. A therapeutic controversy. Thyroid hormone treatment: When and what? J Clin Endocrinol Metab 1995;80:2873-2883.
2. Toff AD. Thyroxine therapy. N Engl J Med 1994;331:174-180.
3. Sawin CT, Surks MI, London M, Ranganathan C, Larsen PR. Oral thyroxine: variation in biologic action and tablet content. Ann Intern Med 1984;100:641-645.
4. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. N Engl J Med 1987;316:764-770.
5. Gharib II, James EM, Charboneau JW, Naessens JM, Offord KP, Gorman CA. Suppresive therapy with levothyroxine for solitary thyroid nodules. N Engl J Med 1987;317:70-75.
6. Banovac K, Papic M, Bilsker MS, Zakarija M, McKenzie M. Evidence of hyperthyroidism in apparently cuthyroid patients treated with levothyroxine. Arch Intern Med 1989;149:809-812.
7. Larsen PR. Thyroid-Pituitary Interaction. Feedback regulation of thyrotropin secretion by thyroid hormones. N Engl J Med 1982;306:23-32.
8. Stoffer SS, Szpunar WE. Potency of levothyroxine products. JAMA 1984;251:635-636.
9. Hennessey JV, Kenneth DB, Wartofsky L. The equivalency of two L-Thyroxine preparations. Ann Intern Med 1985;102:770-773.
10. Hennessey JV, Evaul JE, Tseng YC, Berman KD, Wartofsky L. L-Thyroxine dosage: a reevaluation of theraphy with contemporary preparations. Ann Intern Med 1986;105:11-15.
11. Singer PA, Cooper DS, Levy EG, Ladenseon PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-812.
12. Grupo de Trabajo del Tiroides. Sociedad Española de Endocrinología Pediátrica de la Asociación Española de Pediatría. Recomendaciones para optimizar los resultados de los programas de screening neonatal del hipotiroidismo congénito. An Esp Pediatr 1995;43:53-58.
13. Roti E, Minelli R, Gardini E, Braverman LE. The use and misuse of thyroid hormone. Endocr Rev 1993;14:401-423.
14. Morreale G, Escobar F. Brain damage and thyroid hormone. En: Burrow GN, Dussault JH (eds). Neonatal Thyroid Screening. New York. Raven Press, 1980; págs. 25-50.
15. Rovet JF, Ehrlich RM, Donher E. Long-term neurodevelopmental correlates of treatment adecuacy in screening hypothyroid children. Pediatric Research 1993;33(S5):91.
16. Sakata S, Nakamura S, Miura K. Autoantibodies against thyroid hormones or iodothyronine. Ann Intern Med 1985;103:579-589.
17. Escalante DA, Arem N, Arem R. Assessment of interchange-ability of two brands of levothyroxine preparations with as third-generations TSH assay. Am J Med 1995;98:374-378.
18. 3. J Clin Endocrinol Metab 1983;56:1152-1163.